National Medical Research Center for Hematology
Nom variantlari: Federal State Institution Hematology Research Center · NMRC for Hematology · ГУ Гематологический научный центр РАМН · Гематологический научный центр Министерства здравоохранения РФ · ФГБУ «НМИЦ Гематологии» Минздрава России · Федеральное государственное бюджетное учреждение «Гематологический научный центр» Министерства здравоохранения и социального развития Российской Федерации · Центральный научно-исследовательский институт гематологии и переливания крови · Центральный ордена Ленина институт переливания крови
- Davlat:
- RU
2
h-indeks
6
Iqtiboslar
16
Asarlar
42
Mualliflar
Vaqt boʻyicha
Vaqt boʻyicha tahlil
Iqtibos sharhi
Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)
- Nashrlar
- Iqtiboslar
Iqtibos tarixi
Nashr tarixi
h-indeks evolyutsiyasi
Yillar boʻyicha jamlangan h-indeks
Eng koʻp iqtibos qilingan asarlar
- [Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].20100 iqtibos
- Chronic Myeloid Leukemia Diagnosed during Pregnancy: Therapy, Outcomes and Follow-up20180 iqtibos
- Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database20190 iqtibos
- PF666 LOW JAK2 V617F ALLELE BURDEN PHI‐NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS MAY ASSOCIATE WITH ADDITIONAL CALR OR MPL MUTATIONS20190 iqtibos
- The frequency of detection of anti-HBc in blood donors from four regions of Russia20210 iqtibos
- Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry20220 iqtibos
- POSTER: CML-491 Case Report of Variant Translocations and Atypical BCR::ABL Transcripts in CML Management20230 iqtibos
- POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 iqtibos
- POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 iqtibos
- Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry20240 iqtibos